Cargando…
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
Noninvasive disease monitoring and risk stratification by circulating tumor DNA (ctDNA) profiling has become a potential novel strategy for patient management in B-cell lymphoma. Emerging innovative therapeutic options and an unprecedented growth in our understanding of biological and molecular fact...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417989/ https://www.ncbi.nlm.nih.gov/pubmed/35701522 http://dx.doi.org/10.1038/s41375-022-01618-w |